Protective Effect of Targeted Fluid Therapy on Patients with One-Lung Ventilation

Ji-Bo Zhao; Yuan-Li Li; Deng-Yun Xia; Xiao-Jia Sun; Fu-Long Li; Zhen Xing

doi:10.1155/2022/7850031

Protective Effect of Targeted Fluid Therapy on Patients with One-Lung Ventilation

Evid Based Complement Alternat Med. 2022 May 6:2022:7850031. doi: 10.1155/2022/7850031. eCollection 2022.

Authors

Ji-Bo Zhao¹, Yuan-Li Li², Deng-Yun Xia¹, Xiao-Jia Sun¹, Fu-Long Li¹, Zhen Xing¹

Affiliations

¹ Department of Anesthesia, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei, China.
² Department of Critical Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei, China.

Abstract

Objective: To evaluate the protective effect of target-directed fluid therapy on the lungs and postoperative rehabilitation in elderly patients with single-lung ventilation undergoing total endoscopic radical resection of esophageal cancer.

Methods: Seventy elderly patients who underwent total endoscopic radical resection of esophageal cancer from January 2017 to December 2019 in our hospital were selected and divided into two groups by the random number table method: the goal-directed fluid treatment group (group G, n = 35) and the control group (group C, n = 35). Venous blood was extracted before surgery (T1), at the end of free esophagus (T2) by thoracoscopy, at the end of abdominal surgery (T3), and at the end of surgery (T4). IL-6 and IL-10 levels were detected by ELISA. The clinical pulmonary infection score (CIPS) was used to evaluate the pulmonary inflammation on the second day after surgery and the occurrence of complications. Duration of antibiotic use and length of hospital stay were recorded.

Results: At T1, there were no significant differences in IL-6 and IL-10 levels between the two groups (P > 0.05). At T2, the IL-6 level in group G increased to 26.65 ± 1.80 pg/ml but was significantly lower than that in group C (32.28 ± 3.22 pg/ml) (P < 0.01). At T3 and T4, IL-6 and IL-10 levels in group G were significantly lower than those in group C (P < 0.01). The CIPS score of group G was lower than that of group C (1.5 ± 1.0 vs 2.7 ± 1.4), and the duration of antibiotic use in group G was shorter than that in group C (211.2 ± 15.4 vs 232.6 ± 18.7 h), with statistical significance (P < 0.01). The incidence of complications in group G was lower than that in group C (28.6% vs 40.0%), and the length of hospital stay in group G was shorter than that in group C (10.5 ± 1.7 vs 11.2 ± 1.9 days), but there was no significant difference between the two groups (P > 0.05).

Conclusion: Target-directed fluid therapy inhibited inflammatory cytokine levels and had better lung protection, but no significant benefit in the complications or the length of hospital stay was observed.

Publication types

Retracted Publication